Showing Results for
- Academic Journals (12)
Search Results
- 12
Academic Journals
- 12
- Search Terms:
- 1From: Pharmacogenomics. (Vol. 8, Issue 1) Peer-ReviewedAuthor(s): Saye Khoo 1 Your laboratory recently developed a test allowing the amount of HIV drugs in the blood to be monitored. To what extent has the test been taken up by European medical providers? How do you...
- 2From: Pharmacogenomics. (Vol. 8, Issue 1) Peer-ReviewedAuthor(s): Dan Buskila [[dagger]] 1 , Piercarlo Sarzi-Puttini 2 , Jacob N Ablin 3 Keywords: familial aggregation; fibromyalgia; genetics; gene polymorphisms Fibromyalgia syndrome (FMS) is a chronic, generalized...
- 3From: Pharmacogenomics. (Vol. 8, Issue 1) Peer-ReviewedAuthor(s): Howard McLeod 1 Has the potential impact of pharmacogenomics (PGx) in medicine been oversold to the public, and how concerned will the public be over ethical issues? I think the impact was not oversold,...
- 4From: Pharmacogenomics. (Vol. 8, Issue 1) Peer-ReviewedAuthor(s): Sachie Inoue 1 , Masayuki Hashiguchi 1 , Takeshi Chiyoda 2 , Yukiko Sunami 2 , Takanori Tanaka 2 , Mayumi Mochizuki [[dagger]] 1 Keywords: 5,10-methylenetetra-hydrofolate reductase; allelic frequency;...
- 5From: Pharmacogenomics. (Vol. 8, Issue 1) Peer-ReviewedAuthor(s): John Carlquist 1 Your group is involved with work to identify mutations that affect the response of patients to heart failure drugs. Do you think this will lead to the eventual individualization of...
- 6From: Pharmacogenomics. (Vol. 8, Issue 1) Peer-ReviewedA panel of 23 protein biomarkers in cerebrospinal fluid have been identified by scientists at Cornell University in Ithaca and Weill Cornell Medical College in New York (NY, USA). These proteins act as a neurochemical...
- 7From: Pharmacogenomics. (Vol. 8, Issue 1) Peer-ReviewedAuthor(s): Giuseppe Pasqualetti 1 , Romano Danesi 1 , Mario Del Tacca 1 , Guido Bocci [[dagger]] 1 Keywords: bevacizumab; pharmacogenetics; single nucleotide polymorphism; tyrosine kinase inhibitors; vascular...
- 8From: Pharmacogenomics. (Vol. 8, Issue 1) Peer-ReviewedAuthor(s): Eugene Lin [[dagger]] 1 , Yuchi Hwang 1 , Kung-Hao Liang 1 , Ellson Y Chen 1 Keywords: association studies; epistasis; genomic databases; haplotypes; pattern-recognition; pharmacogenomics; single...
- 9From: Pharmacogenomics. (Vol. 8, Issue 1) Peer-ReviewedAuthor(s): Justin Stebbing [[dagger]] 1 3 , Vered Stearns 2 , Nancy E Davidson 2 There is a hierarchy of pharmacogenetic information that commences with all single nucleotide polymorphisms (SNPs) and exon-based...
- 10From: Pharmacogenomics. (Vol. 8, Issue 1) Peer-ReviewedAuthor(s): Chava Kimchi-Sarfaty 1 2 , Andrew H Marple 1 , Shiri Shinar 1 , Avraham M Kimchi 3 , David Scavo 1 , M Isabella Roma 1 , In-Wha Kim 1 , Adam Jones 1 , Mili Arora 1 , John Gribar 1 , David Gurwitz 4 , Michael...
- 11From: Pharmacogenomics. (Vol. 8, Issue 1) Peer-ReviewedAuthor(s): Dana C Dolinoy 1 Environmental epigenetics Traditional research on the combined effects of genetics and the environment investigates how individuals differ in susceptibility to disease and how...
- 12From: Pharmacogenomics. (Vol. 8, Issue 1) Peer-ReviewedAuthor(s): Justin Stebbing 1 Pharmacogenetics provides powerful tools to assess cancer risk. What are the implications for the patient and for the health systems offering oncology services? While personalized...